Even supporters of mRNA vaccination against COVID-19 might be surprised at just how much higher death rates are among the ...

How can doctors talk about the net benefits of COVID shots if they won’t acknowledge the worst risk? On the Friday after ...

Vaccinated adults had a 74 percent lower risk of dying from COVID-19—and a 25 percent lower risk of dying, period.

The industry’s mRNA alliance is demanding steady FDA leadership, warning that the current “unprecedented turmoil” at the ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the results of a clinical trial.

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

The Department of Health and Human Services recently canceled $500 million in funding for vaccine research that it had previously pledged to scientists.

H3N2, a potent influenza A subtype, is driving significant flu outbreaks globally, causing substantial hospitalizations, ...

FRIDAY, Nov. 21, 2025 (HealthDay News) — Pfizer’s mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 ...

Vinay Prasad’s memo makes alarming claims about the COVID-19 vaccine — including the assertion, made without any supporting ...

Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.

Researchers in Newcastle are seeking to find volunteers for a new clinical trial ...